Get started
Author

Hiroki Shirasaki

Observed names: H SHIRASAKI, H Shirasaki, H. Shirasaki, Hiroki SHIRASAKI
ORCID: 0000-0002-8222-7086
Observed ORCID: 0000-0002-8222-7086
OpenAlex ID: A5002218424
Sweet's syndrome associated with granulocyte colony-stimulating factor.
1998 · M Hasegawa, S Sato, et al. · PubMed · 59
Effects of dexamethasone on cytokine and phorbol ester stimulated c-Fos and c-Jun DNA binding and gene expression in human lung
1994 · IM Adcock, CR Brown, et al. · European Respiratory Journal · 51
PDF
Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non–Small-Cell Lung Cancer and High PD-L1 Tumor Expression
2020 · Yuichi Tambo, Takashi Sone, et al. · Clinical Lung Cancer · 35
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
2019 · Hideharu Kimura, Tomoyuki Araya, et al. · 癌症：英文版 · 31
PDF
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings
2022 · Taro Yoneda, Takashi Sone, et al. · Clinical Lung Cancer · 28
Up-regulation of ICH-1
1999 · Masaki Fujimura, Kazuo Kasahara, et al. · Journal of Cancer Research and Clinical Oncology · 21
Pulmonary Neoplasms in Patients with Birt-Hogg-Dubé Syndrome: Histopathological Features and Genetic and Somatic Events
2016 · Mitsuko Furuya, Reiko Tanaka, et al. · PLoS ONE · 16
PDF
Small cell lung cancer accompanied by lactic acidosis and syndrome of inappropriate secretion of antidiuretic hormone
1998 · Masaki Fujimura, Hiroki Shirasaki, et al. · Lung Cancer · 15
Five-year efficacy and safety of pembrolizumab as first-line treatment in patients with non-small cell lung cancer with PD-L1 tumor proportion score ≥50 %: A multicenter observational study
2025 · Yuichi Tambo, Takashi Sone, et al. · Lung Cancer · 14
PDF
Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines.
1997 · T Bando, M Fujimura, et al. · PubMed · 14
Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines
1996 · K Kasahara, M Fujimura, et al. · British Journal of Cancer · 14
PDF
Rhabdomyolysis Complicating Polymicrobial Sepsis in a Patient with Acute Leukemia.
1996 · Hisashi FUNADA, Hiroki SHIRASAKI, et al. · Internal Medicine · 13
PDF
Endoscopic Management for Broncholithiasis With Bronchoesophageal Fistula
2007 · Tetsuhiko Go, Hiroaki Kobayashi, et al. · The Annals of Thoracic Surgery · 9
PDF
A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer.
2006 · Kazuo Kasahara, Hideharu Kimura, et al. · PubMed · 7
Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: Multicenter phase II trial
2007 · Tomoyuki Araya, Kazuo Kasahara, et al. · Lung Cancer · 6
A case of prolonged COVID ‐19 treated with tixagevimab/cilgavimab
2023 · Takahiro Shimizu, Hiroki Shirasaki, et al. · Respirology Case Reports · 5
A phase II trial of biweekly administration of vinorelbine (V) and gemcitabine (G) in elderly patients (Pts) with advanced non-small cell lung cancer (NSCLC)
2004 · H. Kimura, K. Kasahara, et al. · Journal of Clinical Oncology · 5
Stimulation of beta-adrenoceptor enhances sensitivity to cisplatin in non-small cell lung cancer cell lines
1997 · T Bando, M Fujimura, et al. · International Journal of Oncology · 4
Anti-MDA5 antibody-positive interstitial lung disease without prominent skin or muscle manifestations: A high-risk and potentially overlooked subgroup
2025 · Atsushi Muto, Satoshi Watanabe, et al. · Respiratory Medicine · 3
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer
2024 · Nanao Terada, Hayato Koba, et al. · Translational Lung Cancer Research · 3
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)
2021 · Shigeru Tanzawa, Sunao Ushijima, et al. · Therapeutic Advances in Medical Oncology · 2
A retrospective analysis of the efficacy of immune checkpoint inhibitors (ICIs) to advanced non-small cell cancer (NSCLC) patients (pts) with central nerve system (CNS) metastasis.
2018 · Takashi Sone, Kazuo Kasahara, et al. · Journal of Clinical Oncology · 2
A phase II trial of weekly paclitaxel (P) and gefitinib (G) in patients (pts) with gefitinib-refractory or -resistant non-small cell lung cancer (NSCLC)
2004 · K. Kasahara, T. Sone, et al. · Journal of Clinical Oncology · 2
[A case of adenocarcinoma complicated with massive leukocytosis and hypercalcemia].
2000 · K Nobata, M Fujimura, et al. · PubMed · 2
Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia
1996 · Takuma Bando, Kazuo Kasahara, et al. · Journal of Cancer Research and Clinical Oncology · 2
Works count: 39
Citation count: 365
H-index: 12
I10-index: 12
Year
Topic
Type